Cargando…
Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1–ROS1 gene fusion in pediatric angiosarcoma
Angiosarcomas are rare, malignant soft tissue tumors in children that arise in a wide range of anatomical locations and have limited targeted therapies available. Here, we report a rare case of a pediatric angiosarcoma (pAS) with Li–Fraumeni syndrome (LFS) expressing a novel NOTCH1–ROS1 gene fusion....
Autores principales: | Jain, Payal, Iyer, Sudarshan, Straka, Joshua, Surrey, Lea F., Pogoriler, Jennifer, Han, Harry, Smith, Tiffany, Busch, Christine, Fox, Elizabeth, Li, Marilyn, Waanders, Angela J., Resnick, Adam, Davare, Monika A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632357/ https://www.ncbi.nlm.nih.gov/pubmed/36307212 http://dx.doi.org/10.1101/mcs.a006222 |
Ejemplares similares
-
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
por: Iyer, Sudarshan R, et al.
Publicado: (2023) -
Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation
por: Jain, Payal, et al.
Publicado: (2018) -
A blast from the past: ROS1 on the brain
por: Odintsov, Igor, et al.
Publicado: (2019) -
ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma
por: Marks, Eric I., et al.
Publicado: (2019) -
Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways
por: Jain, Payal, et al.
Publicado: (2017)